Wednesday, 11 May 2016 11:41

Hardev Karar we salute you. R.E.S.P.E.C.T

Written by
So now it's common knowledge that the Indian patent office has approved Gilead's sofosbuvir patent but.... What Happened to the Indian Official that Rejected the US Drug Company Gilead’s Patent Application in 2015? It appears that being a man of honour is…
End of Hepatitis C Tourism? For more than a year, Hepatitis C patients who could not afford the high price tag of the novel Hepatitis C drugs in their respective countries, could go to India and buy the medicines they needed to…
According to the Center for Disease Control and Prevention (CDC), Hepatitis C is currently the most deadly infectious disease in the US. The findings are based on new government data about Hepatitis C related deaths in 2014. What is even more concerning…
Meet Steve. Steve is 58 years old and had Hepatitis C for 10 years. With all the rumors about these new direct acting antivirals (DAA) treatment being so successful, he and his doctor make a decision to start sofosbuvir-based treatment of his…
As a part of the effort to solve the unavailability of modern Hepatitis C drugs, REDEMPTION-1 clinical trials were conducted in order to determine the safety and efficacy of generic direct acting antivirals (DAA) to treat Hepatitis C. The trials were lead by Dr.…
The International Liver Congress is a 5-day event where scientists and medical experts from all over the globe come up to speed with what is new in the latest liver research. Arguably, it is the biggest event connected with liver diseases in…
Thursday, 14 April 2016 18:26

One poignant post that says it all...

Written by
Thank you all, I wish I could say Harvoni cured me, but it did not. Generic sofosbuvir and ledipasvir from China did. I would still be very sick without it. Gilead is a hedge fund under the guise of a pharmaceutical company. They want…
Thursday, 14 April 2016 09:12

$300 Hepatitis C Cure Could be Available Within 2 Years

Written by
14th April 2016 - The world renown International Liver Congress 2016 started yesterday. One of the current highlights is a study by DNDi (Drugs for Neglected Diseases initiative) which introduced a new ravidasvir and sofosbuvir combo for treating Hepatitis C. According to clinical…
By now pretty much everybody knows which common disease will your wallet hate the most: Hepatitis C. Let us look at a list of the most expensive drugs in the US. There are top 10 on the list; can you guess how…
Wednesday, 06 April 2016 10:04

18 Ways To Cope With Hepatitis C

Written by
Hepatitis C is a disease that many people have to live with for years. Even with the newly discovered treatment, some people still choose to forgo therapy due to high prices of medications. We have prepared a list of things every Hepatitis…
Where does India come in in the pharmaceutical industry? This is how drug industry works. New drugs are being developed by big pharmaceutical corporations in the developed world (mostly the US and Europe). When such originator drugs are launched, they are usually very…
Hepatitis C is a disease that mostly affects people after 40 years of age. Being an asymptomatic disease, Hepatitis C virus (HCV) can be hiding in the liver for more than a decade without apparent effects. This gives us an indication about…
We have secured a viable cure for Hepatitis C with a sofosbuvir-based regimen. However, healing the existing patients is not enough. We also have to approach systematic treatment from another angle - reduce Hepatitis C spread. In the developed world, the newly…
Tuesday, 22 March 2016 09:13

Hepatitis C Burden and Distribution in Africa

Written by
The Hepatitis C virus (HCV) infects people all over the world but Africa is a special case. The virus causes a chronic liver disease and is among the leading factors of liver problems in the world. The statistics from the World Health…
I just opened a textbook for medical students from 1980s, doing a research on Hepatitis C. Here's the interesting thing: When looking for liver diseases, in particular Hepatitis, the table of content only lists Hepatitis A and Hepatitis B. Where is Hepatitis…
Hepatitis C treatment prices are one of the most discussed issues in the medical world today. The patients want lower prices. The doctors have spoken against the high prices, and even the US Senate had a hearing about it. But the price of…
Insurance companies are a very important part of the lives of many Hepatitis C patients. With the effective new drugs costing up to $100,000, the majority of people are counting on their insurance companies to foot the bill. However, the staggering prices…
The last two years or so have been very successful for Hepatitis C treatments. The revolutionary new line of drugs that was registered for chronic Hepatitis C since 2013 feature over 90% cure rates and a pill-per-day regimens. Asunaprevir is the latest…
Even before Sovaldi, the first modern antiviral medicine for Hepatitis C, obtained FDA's market authorisation, a group of scientists from University of Liverpool correctly predicted the looming problem - Hepatitis C drugs will become one of the costliest and thus hardly accessible…
Saturday, 27 February 2016 03:42

PBS Pricing - Take a deep breath....

Written by
So I guess like a lot of people I've been wondering how good a deal the PBS negotiated. Last week I heard that a major public hospital had ordered 10 lots for $66,000 but thought that must be wrong. Given the pharmacists have to…
Here are some quick facts about Hepatitis C and US Army Veterans. Since 2013, we have a cure for Hepatitis C that is about 95% successful In the US, more than 200,000 Army Veterans suffer from Hepatitis C Here is what US…
Today we bring you a staggering story about a UK-based surgeon who was diagnosed with Hepatitis C in 2008. One of the biggest Hepatitis C stories of 2016 Jump to 2016: Yesterday more than 8000 of his former patients were mailed an…
Sunday, 21 February 2016 11:25

Europe plans to eliminate Hepatitis C by 2030

Written by
"What would have taken a hundred years for us to achieve, is now at hand!" were the first words of Prof. Angelos Hatzakis who serves at EU Council in Brussels as a co-chair of Hepatitis B and C Public Policy Association. In…

Copyright © 2015-2019 FixHepC

Back to Top